Advertisement

Advertisement

Current Clinical Care

The Launch of the Dementia Educational Resource: Interview With the Editor-in-Chief Dr. Michael Gordon

The Launch of the Dementia Educational Resource: Interview With the Editor-in-Chief Dr. Michael Gordon

Teaser: 


Michael Gordon, MD, MSc, FRCPC, FACP, FRCPEdin
Geriatrician, ethicist, educator, speaker, author.

Following on the footsteps of the recent announcement of the launch of the Dementia Educational Resource, www.HealthPlexus.net recently interviewed Dr. Michael Gordon who was appointed as Editor-in-Chief for the newly re-focused educational channel. Dr. Barry Goldlist asked Dr. Gordon a few questions about the format and the plans for this project.

Key Topics for Your Adult Patients

Key Topics for Your Adult Patients

Teaser: 

It is my pleasure to introduce the latest issue of The Journal Of Current Clinical Care. This current issue has a number of key articles, for the primary care physician and specialist, alike that summarize a practical approach to important issues in daily practice.

From Dr. Shabbir Alibhai, we have an update on cancer screening in the older adult. Cancer remains a major cause of morbidity and mortality in older adults—as more than half of all new cancers and over 70% of cancer deaths occur in the over -65 age group. Cancer screening is an important tool to decrease the incidence and mortality from cancer in older adults. Dr. Alibhai reviews the evidence and the screening recommendations for this population.

Dr. James Wright reviews the choice of first line anti-hypertensive agents in the older adult. This article examines the evidence for the different classes of first-line antihypertensive drugs in the context of four important treatment goals: reduction in mortality and morbidity; efficacy in lowering blood pressure; ensuring tolerability; and minimizing cost.

Many may consider Parkinson’s disease as primarily a motor disorder. However, it has important effects on cognition and personality. Important neuropsychiatric sequelae of Parkinson’s, known as impulse-control disorders, can have significant negative effects on patients and their families. Examples are pathological gambling and hypersexuality. Dr. Andrew Johnson reviews the treatment options for this condition, including dopamine agonist dose reduction or cessation, the use of psychosocial strategies, and deep-brain stimulation of the subthalamic nucleus.

Proteinuria is frequently a marker of unsuspected kidney disease, progressive atherosclerosis, or a systemic disease. A strong correlation exists between urinary protein excretion and the progression of renal failure. Proteinuria is also a strong and independent predictor of increased risk for cardiovascular disease and death, especially in people with diabetes, hypertension, and chronic kidney disease. Dr. Fatemeh Akbarian et al. review the diagnosis and treatment of proteinuria in the adult.

Dr. Michael Gordon’s article discusses the sensitive issue of conflict among family members in the context of substitute decision making for patients with dementia. The article emphasizes that physicians must use the art of medicine, including their communication skills and sensitivities, to help families resolve their differences so that the best possible care can be provided to their family members.

I hope you enjoy the issue. As always your comments are welcome.

The Canadian Conference on Dementia: Past, Present and Future

The Canadian Conference on Dementia: Past, Present and Future

Teaser: 

An interview of Dr. Barry Goldlist with Dr. Ron Keren, the founder and chair of CCD
 


Dr. Ron Keren, MD, FRCPC
Dr. Ron Keren was born and raised in Vancouver and received his medical degree at the University of Tel-Aviv, Israel. Dr. Keren completed his residency training in Psychiatry at the University of Maryland, where he also completed a clinical fellowship in Geriatric Psychiatry.


 

Optimizing Acne Care

Optimizing Acne Care

Teaser: 

Publication of THE LATEST IN ACNE CARE supplement was made possible by an unrestricted educational grant from Galderma Canada Inc.

Maha Theresa Dutil, MD, M.Ed, FRCPC, Assistant Professor of Medicine, Division of Dermatology, University of Toronto, Toronto, ON.

One of the marked changes in the practice of dermatology over the past thirty years has been the increased focus on acne. What was once considered a universal rite of passage that occasionally caused deeply disturbing scars is now considered—by patients and doctors alike—an insufferable condition that must be treated. Perhaps as a sign that available treatments are increasingly successful, acne is showing signs of affecting popular culture. Kid Acne, a British artist (not his real name!), decided to make his affliction his signature so as to stand out in the crowded hip-hop scene. The Uruguayan movie Acné (as you would have guessed, about a thirteen-year-old boy coming of age while enduring acne outbreaks) was a hit of Spanish-speaking cinema in 2008. Acne for Dummies by Dr. Herbert P. Goodheart (a remarkably good book!) ranks a respectable 76th in skin care/ beauty books on Amazon.ca.

Success has bred the desire for even more success. This supplemental publication to Dermatology Times on "Innovations in Acne Care: The Latest Guidelines and Treatment Options" sheds light on new approaches that will be helpful to specialists and GPs alike. Dr. Neil Shear's "Newest Guidelines for the Treatment of Acne" discusses the acne guidelines...

2009 Guidelines for the Treatment of Acne

2009 Guidelines for the Treatment of Acne

Teaser: 

Neil H. Shear, MD, FRCPC, FACP,

Professor and Chief of Dermatology, Professor of Medicine, Pediatrics and Pharmacology, University of Toronto Faculty of Medicine; Head of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON.

CLINICAL TOOLS

Abstract: This article summarizes key statements from the 2009 Global Alliance to Improve Outcomes in Acne Group's therapeutic guidelines, published as a supplement in the Journal of the American Academy of Dermatology (JAAD). It offers an algorithm for acne treatment, as well as addresses important statements from the committee on acne pathophysiology, epidemiology, and the latest research findings, as they pertain to the guidelines.
Key Words: acne, treatment guidelines, adherence, antibiotic resistance, maintenance.
Dermatologists should be actively contributing to educating other clinicians that acne is a chronic disease.
Despite many extensive educational programs, the committee sees an ongoing need to urgently reduce the use of antimicrobial therapies, especially as single agents.
A combination of a topical retinoid plus an antimicrobial agent is first-line therapy for most patients with acne (a finding based on clinical trials with over 16,000 total subject participants in studies of Level I evidence quality), as it targets multiple pathogenic features and both inflammatory and noninflammatory acne lesions.
The Global Alliance 2009 update affirms that topical retinoids should be fundamentally a core component of an acne therapy regimen for stages I to III. The committee's consensus is that early and appropriate treatment, continued for as long as necessary, is the best approach to mitigating scarring for acne patients.
Implement strategies to improve adherence to therapy (e.g., medication reminders, self-monitoring with diaries, support groups, telephone follow-up) to ensure success.
Treat acne as quickly and as efficiently as possible to achieve the best therapeutic outcomes, and to improve patient satisfaction, limit treatment expenses, and mitigate scarring.
To have access to full article that these tools were developed for, please subscribe. The cost to subscribe is $80 USD per year and you will gain full access to all the premium content on www.healthplexus.net, an educational portal, that hosts 1000s of clinical reviews, case studies, educational visual aids and more as well as within the mobile app.